510(k)s Are Subject To Good Laboratory Practice Regs – FDA Draft Guidance
Executive Summary
Device manufacturers must declare compliance or explain noncompliance to good laboratory practice regulations for nonclinical studies in all premarket submission types, according to new draft guidance. This has not been the requirement for 510(k)s up until now, says the former CDRH 510(k) policy chief.
You may also be interested in...
510(k) Guidance Footnote May Signal Greater FDA Oversight Of Preclinical Testing
Device industry experts say a seemingly minor footnote to the recent 510(k) program draft guidance could create a new requirement for nonclinical studies.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.